Burden of the Cardiovascular Diseases in Central Asia

Main Article Content

Altyn Aringazina
Tleuberdi Kuandikov
Viktor Arkhipov

Abstract

Cardiovascular diseases (CVD) are now the number one cause of death in low- and middle-income countries, including those in Central Asia (CA). Low- and middle- income countries (LMICs) bear a disproportionate and growing burden of CVD, which constitutes a challenge to national development. CVD account for more than 43% of cases of disability and 9.0% of cases of temporary disability in many developing countries. The high burden of CVD oftentimes results from insufficient preventive care and a lack of education about the prevention and treatment of these diseases. The rapidly growing burden of CVD and other major non-communicable diseases (NCDs) is a global public health threat, especially in Central Asia. Information on cardiovascular risk factors, including hypertension, diabetes, tobacco use, and alcohol use, is traditionally obtained from studies conducted in Europe and North America, which limits our understanding of these factors in Central Asia. In this review, we collected all published information on CVD in Central Asia from 2000 to 2015, which included the websites of the Ministries of Health, the World Health Organization, PubMed, and other published sources.This narrative review describes CVD burden, stroke incidence, and common CVD risk factors in the five post-Soviet countries of Central Asia (Kazakshstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan).

Article Details

How to Cite
Aringazina, A., Kuandikov, T., & Arkhipov, V. (2018). Burden of the Cardiovascular Diseases in Central Asia. Central Asian Journal of Global Health, 7(1). https://doi.org/10.5195/cajgh.2018.321
Section
Reviews

References

Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-254.

Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015;45(3):161-176.

Yusuf S RS, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746-2753.

World Health Organization. World Health Statistics 2009. http://www.who.int/whosis/whostat/2009/en/. Accessed 11 June, 2018.

Starr SF. Lost Enlightenment: Central Asia's Golden Age from the Arab Conquest to Tamerlane. 2015.

Health of the population of the Republic of Kazakhstan and the activities of health organizations in 2014. Ministry of Health of the Republic of Kazakhstan;2015.

Aringazina A. Development and sustainability: The Challenge of Social Change. London: ZED Books Ltd.; 2016.

Health of population and health care in the Republic of Kazakhstan in 2013. 2013; www.medinfo.kz. Accessed 11 June, 2018.

State Program on Health Systems' Development for the years 2011 - 2015. Ministry of Health of the Republic of Kazakhstan;2010.

Order of the Ministry of Health #145. Ministry of Health of the Republic of Kazakhstan; 2011.

Order of the Ministry of Health #704. Ministry of Health of the Republic of Kazakhstan; 2010.

Basic indicators of population health and activity of health organizations of the Republic of Kazakhstan from 2000 to the present. http://www.medinfo.kz/#/dpsraion. Accessed 11 June, 2018.

Report on the Global Tobacco Epidemic, 2013. World Health Organization;2013.

Law of the Republic of Kazakhstan on Ratification of the WHO Framework Convention on Tobacco Control. 2006.

Decision No. 6 of the Chief Sanitary Doctor: "On the introduction of a ban on smoking hookah in public places.". Ministry of Health of the Republic of Kazakhstan; 2013.

Organization WH. Global status report on alcohol and health 2014. Geneva2014.

State Programme "Densaulyk" for Health Care System Development in Republic of Kazakhstan 2016 - 2019. 2016.

V.V. Benberin VYD, A.K. Kaptagaeva, Т.А. Voshchenkova, Т.Т. Kulkhan Brain stroke as the cause of death in the Republic of Kazakhstan: some risk management factors. The journal of neuroscience of bm Mankovskyi. 2016;4(1).

Jill Farrington FRP, Alexei Yakovlev, Oxana Rotar. Review of acute care and rehabilitation services for heart attack and stroke in Kyrgyzstan. World Health Organization;2017.

National Statistics Data 2015. Bishkek: Centre for Medical Information, 2015.

Institute of Health Metrics and Evaluation. Kyrgyzstan. http://www.healthdata.org/kyrgyzstan. Accessed 11 June, 2018.

Mid-term Review Report of Den Sooluk National Health Reform Program of the Kyrgyz Republic for 2012-2016 Bishkek2016.

M Jakab LH, B Loring, J Tello, T Egruder, M Kontas. Better noncommunicable disease outcomes: challenges and opportunities for health systems. Kyrgyzstan country assessment. Copenhagen: World Health Organization;2014.

Aida Abdraimova AI, Aida Zurdinova Reasons for low health care seeking among men with hypertension in Kyrgyzstan. Bishkek: World Health Organization;2016.

World Bank. Kyrgyz Republic. https://data.worldbank.org/country/kyrgyz-republic.

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study. The Lancet. 2015;385(9963):117-171.

Community Action for Health. http://www.cah.kg. Accessed 11 June, 2018.

T Schuth ea. The Community Action for Health programme in the Kyrgyz Republic. Swiss Red Cross;2014.

Kyrgyzstan STEPS survey 2013: fact sheet. World Health Organization;2015.

Anderson I BM, Obermann K, Temirov A, Ibragimova G. Independent review of Den Sooluk and project in support of the mid-term review. World Health Organization;2016.

Non-Communicable Disease Country Profile: Tajikistan. World Health Organization;2011.

Tajikistan Demographic and Health Survey Statistical Agency under the President of the Republic of Tajikistan;2012.

Baktygul Akkazieva JT, Barton Smith, Melitta Jakab, Konstantin Krasovsky,Nina Sautenkova, Lola Yuldasheva, Mekhri Shoismatuloeva. Better non-communicable disease outcomes: challenges and opportunities for health systems. World Health Organization;2015.

Baktygul Akkazieva JT, Barton Smith, Melitta Jakab, Konstantin Krasovsky,Nina Sautenkova, Lola Yuldasheva, Mekhri Shoismatuloeva, et al. Improving indicators for noncommunicable diseases: barriers and opportunities for health systems. World Health Organization.

Rose G. Sick individuals and sick populations. International Journal of Epidemiology. 2001;30(3):427-432.

Law on Restriction of the Use of Tobacco Products. Dushanbe: Government of the Republic of Tajikistan; 2011.

WHO Framework Convention on Tobacco Control. World Health Organization;2003.

Rural population survey (2009-2010). State Statistical Agency under the President of the Republic of Tajikistan;2011.

Framework Convention on Tobacco Control. Dushanbe: The Government of the Republic of Tajikistan; 2013.

Health of the population and the effectiveness of the work of medical institutions in the Republic of Tajikistan Republican Center for Medical Statistics and Information;2013.

Global Youth Survey on the Use of Tobacco Products Republic of Tajikistan. World Health Organization;2014.

O Smith SN. Improving the situation: The results of the health system in Europe and Central Asia. The World Bank;2013.

List of vital medicines. World Health Organization;2014.

National Development Strategy of the Republic of Tajikistan for 2005-2015. Government of Republic of Tajikistan;2005.

Strategy of health financing for 2005-2015. Government of Republic of Tajikistan;2005.

National Health Strategy of the Republic of Tajikistan for 2010-2020. The Government of the Republic of Tajikistan;2010.

Babadzhanov AS, Rustamova H. Y., Stozharova N. K., Eshboeva K. U. Retrospective analysis of the incidence of the population of Uzbekistan Bulletin of the Tashkent Medical Academy. 2011(3):97-100.

Stozharova N.K. MMD, Sadullaeva K.A., Sharipova S.A. Analysis of prevalence of the cardiovascular diseases in the population of Uzbekistan. Young Scientist. 2015;90(10).

Zhaldasov A. Evaluation of experimental results in urban experimental PHC facilities Tashkent: Center for Social and Marketing Research;2010.

Uzbekistan Health Examination Survey 2002. 2002.

Uzbekistan STEPS survey 2014. World Health Organization;2014.

WHO report on the global tobacco epidemic. World Health Organization;2015.

Tobacco control database for the WHO European Region 2016; http://data.euro.who.int/tobacco/. Accessed 27 December, 2016.

Urban population survey (1998-2003). Dushanbe: State Statistical Agency under the President of the Republic of Tajikistan 2011.

Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223-2233.

Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ : British Medical Journal. 2014;349.

Most read articles by the same author(s)